A major new clinical trial looking into the efficacy of an allogeneic topically applied solution to promote hair regrowth has shown clear and significant improvement in both hair count and hair diameter. The clinical study, undertaken by a reputed in South Korea’s Pusan National University School of Medicine, used mesenchymal Stem Cells (MSC’s) and Adipose-derived Stem Cells (ADRC’s) in a longitudinal 34 patient double-blind, randomised clinical trial and published their findings in the Journal, ‘Stem Cells Translational Medicine’ on 4 April 2020, titled “XXXX”. T&CT is already operational in the field and believes its proprietary technology in the fields of adipose and tissue handling, as we’ll as proven track record in preparations of cell suspension solutions, will result in advances in the field in the coming 2-3 years.
Tissue & Cell Technologies
Rebuilding following breast cancer treatment
